Gene: MEIS2
Official Full Name: Meis homeobox 2provided by HGNC
Gene Summary: This gene encodes a homeobox protein belonging to the TALE ('three amino acid loop extension') family of homeodomain-containing proteins. TALE homeobox proteins are highly conserved transcription regulators, and several members have been shown to be essential contributors to developmental programs. Multiple transcript variants encoding distinct isoforms have been described for this gene. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO36667 | MEIS2 Knockout cell line (HeLa) | Human | MEIS2 | 1:3~1:6 | Negative | Online Inquiry |
KO36668 | MEIS2 Knockout cell line (HCT 116) | Human | MEIS2 | 1:2~1:4 | Negative | Online Inquiry |
KO36669 | MEIS2 Knockout cell line (HEK293) | Human | MEIS2 | 1:3~1:6 | Negative | Online Inquiry |
KO36670 | MEIS2 Knockout cell line (A549) | Human | MEIS2 | 1:3~1:4 | Negative | Online Inquiry |
MEIS2 Gene Knockout Cell Lines represent a significant advancement in the study of gene function and regulation, providing researchers with a powerful tool for investigating the role of the MEIS2 gene in various biological processes. MEIS2, a member of the MEIS family of transcription factors, is implicated in the development of the nervous system, hematopoiesis, and potentially in cancer progression. The knockout cell lines are engineered to silence the MEIS2 gene, allowing for detailed assessments of downstream effects and helping to elucidate its physiological roles.
The primary mechanism involves the use of CRISPR-Cas9 technology, which enables precise editing of the MEIS2 locus to disrupt its coding sequence. By eliminating the expression of MEIS2, researchers can study the resultant phenotypic changes in cellular behavior, differentiation pathways, and interaction with signaling networks. This cellular model facilitates a comprehensive exploration of MEIS2-related molecular pathways, providing valuable insights into its function under both normal and pathological conditions.
In terms of scientific importance, these knockout cell lines are invaluable for biomedical research, particularly in contexts such as neurodevelopmental disorders, where understanding the contribution of MEIS2 may unlock new therapeutic strategies. They are also poised to assist in preclinical studies of drug efficacy, helping to identify potential treatment avenues for diseases linked to MEIS2 deregulation.
The advantages of the MEIS2 Gene Knockout Cell Lines include high specificity and reproducibility, as well as the capacity for high-throughput screening applications, which are essential for comparative studies and drug discovery efforts. Compared to conventional methods of gene knockdown, the CRISPR-Cas9 technology used to create these knockout lines ensures more efficient genome editing and lasting effects on gene function, making them more reliable for long-term studies.
These cell lines hold immense value for researchers aimed at revolutionizing our understanding of gene function and its implications in health and disease. By utilizing MEIS2 Gene Knockout Cell Lines, scientists can uncover essential biological mechanisms and pave the way for innovative therapeutic strategies.
At [Your Company Name], we specialize in providing advanced genetic tools and resources tailored to meet the needs of the research community, ensuring that our products facilitate reliable and reproducible scientific results.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.